European Commission authorises GSK's HIV prevention drug

Canada News News

European Commission authorises GSK's HIV prevention drug
Canada Latest News,Canada Headlines
  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

(Reuters) - The European Commission has authorised GSK's HIV-focused unit ViiV Healthcare's cabotegravir long-acting injectable and tablets, the ...

- The European Commission has authorised GSK's HIV-focused unit ViiV Healthcare's cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday. Cabotegravir is - The European Commission has authorised GSK's HIV-focused unit ViiV Healthcare's cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday.

Cabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually-acquired HIV-1 infection in high-risk adults and adolescents weighing at least 35 kilogrammes, according to the company. Sold under brand name Apretude, it is currently approved for use in the United States, Australia, Zimbabwe, South Africa, Malawi, Botswana and Brazil.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SaltWire Network /  🏆 45. in CA

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

European Commission authorises GSK's HIV prevention drugEuropean Commission authorises GSK's HIV prevention drug(Reuters) - The European Commission has authorised GSK's HIV-focused unit ViiV Healthcare's cabotegravir long-acting injectable and tablets, the ...
Read more »

European shares slip with central banks in focus; Nordic Semiconductor slumpsEuropean shares slip with central banks in focus; Nordic Semiconductor slumps(Reuters) - European shares opened slightly weaker on Monday after sharp gains last week, as investors braced for a week packed with central bank ...
Read more »

European shares ease, with central banks in focus; Lonza drops on CEO exitEuropean shares ease, with central banks in focus; Lonza drops on CEO exitBy Bansari Mayur Kamdar (Reuters) -European shares eased on Monday, after sharp gains last week, as investors braced for a week packed with global central ...
Read more »

European shares ease, with central banks in focus; Lonza drops on CEO exitEuropean shares ease, with central banks in focus; Lonza drops on CEO exitKitco News collects and features the top financial, economic and geopolitical news from around the world. Kitco's aggregated sources include some of the top newswires in the world including the Association Press, Canadian Press, Japanese Economic Newswire, and United Press International.
Read more »

Ryan Fox rallies to win European tour's top event at WentworthRyan Fox rallies to win European tour's top event at WentworthRyan Fox overcame a three-shot deficit and a triple bogey early in the final round Sunday with six birdies on the back nine — the last one from 6 feet on the 18th hole — for a 5-under 67 and a one-shot victory over Aaron Rai and Tyrrell Hatton in the BMW PGA Championship.
Read more »

Ryan Fox rallies to win European tour's top event at WentworthRyan Fox rallies to win European tour's top event at WentworthVIRGINIA WATER, England (AP) — Ryan Fox overcame a three-shot deficit and a triple bogey early in the final round Sunday with six birdies on the back nine — the last one from 6 feet on the 18th hole — for a 5-under 67 and a one-shot victory over Aaro
Read more »



Render Time: 2025-02-23 12:30:44